573 related articles for article (PubMed ID: 32369201)
1. United States Patients' Perspective of Living With Migraine: Country-Specific Results From the Global "My Migraine Voice" Survey.
Gibbs SN; Shah S; Deshpande CG; Bensink ME; Broder MS; Dumas PK; Buse DC; Vo P; Schwedt TJ
Headache; 2020 Jul; 60(7):1351-1364. PubMed ID: 32369201
[TBL] [Abstract][Full Text] [Related]
2. My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed.
Martelletti P; Schwedt TJ; Lanteri-Minet M; Quintana R; Carboni V; Diener HC; Ruiz de la Torre E; Craven A; Rasmussen AV; Evans S; Laflamme AK; Fink R; Walsh D; Dumas P; Vo P
J Headache Pain; 2018 Nov; 19(1):115. PubMed ID: 30482181
[TBL] [Abstract][Full Text] [Related]
3. Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for Migraine.
Buse DC; Yugrakh MS; Lee LK; Bell J; Cohen JM; Lipton RB
J Manag Care Spec Pharm; 2020 Oct; 26(10):1334-1343. PubMed ID: 32678721
[TBL] [Abstract][Full Text] [Related]
4. Effect of Headache-Free Days on Disability, Productivity, Quality of Life, and Costs Among Individuals with Migraine.
Lipton RB; Lee L; Saikali NP; Bell J; Cohen JM
J Manag Care Spec Pharm; 2020 Oct; 26(10):1344-1352. PubMed ID: 32678720
[TBL] [Abstract][Full Text] [Related]
5. Impact of headache frequency and preventive treatment failure on quality of life, disability, and direct and indirect costs among individuals with episodic migraine in the United States.
Dodick DW; Reed ML; Lee L; Balkaran BL; Umashankar K; Parikh M; Gandhi P; Buse DC
Headache; 2024 Apr; 64(4):361-373. PubMed ID: 38523435
[TBL] [Abstract][Full Text] [Related]
6. My Migraine Voice survey: disease impact on healthcare resource utilization, personal and working life in Finland.
Sumelahti ML; Sumanen M; Sumanen MS; Tuominen S; Vikkula J; Honkala SM; Rosqvist S; Korolainen MA
J Headache Pain; 2020 Sep; 21(1):118. PubMed ID: 32993489
[TBL] [Abstract][Full Text] [Related]
7. Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom.
Vo P; Fang J; Bilitou A; Laflamme AK; Gupta S
J Headache Pain; 2018 Sep; 19(1):82. PubMed ID: 30203163
[TBL] [Abstract][Full Text] [Related]
8. Healthcare resource use and indirect costs associated with migraine in Italy: results from the
Martelletti P; Schwedt TJ; Vo P; Ritrovato D; Reilly MC; Naclerio M; Ranjan P; Kleebach J; Joshi P
J Med Econ; 2021; 24(1):717-726. PubMed ID: 33955821
[TBL] [Abstract][Full Text] [Related]
9. Impact of headache frequency and preventive medication failure on quality of life, functioning, and costs among individuals with migraine across several European countries: need for effective preventive treatment.
Buse DC; Pozo-Rosich P; Dupont-Benjamin L; Balkaran BL; Lee L; Jauregui A; Gandhi P; Parikh M; Reuter U
J Headache Pain; 2023 Aug; 24(1):115. PubMed ID: 37612633
[TBL] [Abstract][Full Text] [Related]
10. Impact of migraine on workplace productivity and monetary loss: a study of employees in banking sector in Malaysia.
Wong LP; Alias H; Bhoo-Pathy N; Chung I; Chong YC; Kalra S; Shah ZUBS
J Headache Pain; 2020 Jun; 21(1):68. PubMed ID: 32513174
[TBL] [Abstract][Full Text] [Related]
11. Healthcare utilisation and economic burden of migraines among bank employees in China: a probabilistic modelling study.
Wei D; Wong LP; He X; Loganathan T
J Headache Pain; 2024 Apr; 25(1):60. PubMed ID: 38641794
[TBL] [Abstract][Full Text] [Related]
12. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
[TBL] [Abstract][Full Text] [Related]
13. Economic burden, work, and school productivity in individuals with tuberous sclerosis and their families.
Skalicky AM; Rentz AM; Liu Z; Said Q; Nakagawa JA; Frost MD; Wheless JW; Dunn DW
J Med Econ; 2018 Oct; 21(10):953-959. PubMed ID: 29890870
[TBL] [Abstract][Full Text] [Related]
14. Impact of Myeloproliferative neoplasms on patients' employment status and work productivity in the United States: results from the living with MPNs survey.
Yu J; Parasuraman S; Paranagama D; Bai A; Naim A; Dubinski D; Mesa R
BMC Cancer; 2018 Apr; 18(1):420. PubMed ID: 29653557
[TBL] [Abstract][Full Text] [Related]
15. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
[TBL] [Abstract][Full Text] [Related]
17. Employee and Employer Benefits From a Migraine Management Program: Disease Outcomes and Cost Analysis.
Schaetz L; Rimner T; Pathak P; Fang J; Chandrasekhar D; Mueller J; Sandor PS; Gantenbein AR
Headache; 2020 Oct; 60(9):1947-1960. PubMed ID: 32799346
[TBL] [Abstract][Full Text] [Related]
18. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey.
Messali A; Sanderson JC; Blumenfeld AM; Goadsby PJ; Buse DC; Varon SF; Stokes M; Lipton RB
Headache; 2016 Feb; 56(2):306-22. PubMed ID: 26833083
[TBL] [Abstract][Full Text] [Related]
19. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
Vicente-Herrero T; Burke TA; Laínez MJ
Curr Med Res Opin; 2004 Nov; 20(11):1805-14. PubMed ID: 15537481
[TBL] [Abstract][Full Text] [Related]
20. Four-year review of presenteeism data among employees of a large United States health care system: a retrospective prevalence study.
Allen D; Hines EW; Pazdernik V; Konecny LT; Breitenbach E
Hum Resour Health; 2018 Nov; 16(1):59. PubMed ID: 30413168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
